Cargando…
Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)
Pancreatic neuroendocrine tumours (panNET) are heterogeneous neoplasms usually characterised by slow growth and secretion of hormones, which often cause symptoms. The effect of these symptoms on quality of life (QoL) has not previously been examined in detail. EORTC (European Organisation for Resear...
Autores principales: | Ramage, John K., Friend, Elizabeth, Randell, Jordan, KING, Barbara, Fernandez Ortega, Paz, McNamara, Mairéad G., Kaltsas, Gregory, Falconi, Massimo, Cwikla, Jaroslav, Capdevila, Jaume, Grozinsky‐Glasberg, Simona, Mandair, Dalvinder, Gamper, Eva, Srirajaskanthan, Raj, O Weickert, Martin, Gray, Debra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285342/ https://www.ncbi.nlm.nih.gov/pubmed/35156246 http://dx.doi.org/10.1111/jne.13097 |
Ejemplares similares
-
Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)
por: Megdanova-Chipeva, Vera G., et al.
Publicado: (2020) -
Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study
por: Mandair, Dalvinder, et al.
Publicado: (2022) -
Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence‐free survival
por: Daskalakis, Kosmas, et al.
Publicado: (2022) -
European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
por: Grozinsky‐Glasberg, Simona, et al.
Publicado: (2022) -
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
por: Uri, Inbal, et al.
Publicado: (2018)